Bionic balance: implant aims to steady patients with inner ear disorder

NCT ID NCT04918745

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This trial is testing a combined cochlear and vestibular implant (CVI) in 13 people who have lost both hearing and balance function due to bilateral vestibulopathy. The implant stimulates the nerves for hearing and balance to see if it can improve stability, vision during movement, and walking. Participants will use the device in the hospital for 3 weeks and then at home for 15 months to evaluate safety and effectiveness.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Cochlear Vestibular Implant (CVI) - a device that stimulates both hearing and balance nerves

What this could lead to

If it works, this could lead to a new treatment option for people with severe balance disorders, improving their stability and quality of life.

What could go wrong

This is a very small, early proof-of-concept study with only 13 participants. The device is experimental, and it may not work for everyone or could cause side effects like worsened hearing or balance.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BILATERAL VESTIBULAR LOSS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Bilateral Vestibulopathy idiopathic bilateral vestibulopathy sensorineural hearing loss disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Maastricht UMC+

    Maastricht, Limburg, 6229 HX, Netherlands